MS Speaks
Multiple Sclerosis => MS - RESEARCH AND NEWS => Topic started by: agate on September 15, 2021, 09:18:59 pm
-
From PubMed (September 14, 2021)--"Comorbidity and persistence of disease-modifying therapy use in relapsing remitting multiple sclerosis":
https://pubmed.ncbi.nlm.nih.gov/34517192/